819091

Covis Pharma GmBH — FEI 3008152278

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 7, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Waltham, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration